PHAT (STOCKS)
Phathom Pharmaceuticals, Inc. Common Stock
$9.180000
+0.010000 (+0.11%)
Prev close: $9.170000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Steven L. Basta
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $758.38M
- Employees
- 427
- P/E (TTM)
- -7.20
- P/B (TTM)
- -2.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.21 | $-0.26 | +0.0465 | +18.13% |
|
Mar 2026 (Q1)
|
$-0.37 | $-0.33 | -0.0414 | -12.60% |
|
Dec 2025 (Q4)
|
$-0.29 | $-0.39 | +0.0991 | +25.47% |
|
Sep 2025 (Q3)
|
$-0.41 | $-0.56 | +0.1459 | +26.25% |
Financial Statements
| Revenues | $239.66M |
| Benefits Costs and Expenses | $259.26M |
| Cost Of Revenue | $40.93M |
| Costs And Expenses | $324.03M |
| Gross Profit | $198.73M |
| Nonoperating Income/Loss | -$58.43M |
| Operating Expenses | $239.38M |
| Selling, General, and Administrative Expenses | $209.27M |
| Research and Development | $30.11M |
| Operating Income/Loss | -$40.64M |
| Income/Loss From Continuing Operations After Tax | -$99.07M |
| Income/Loss From Continuing Operations Before Tax | $72.26M |
| Net Income/Loss | -$99.07M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$99.07M |
| Net Income/Loss Available To Common Stockholders, Basic | -$99.07M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.26 |
| Diluted Earnings Per Share | -$1.26 |
| Basic Average Shares | 156,602,836 |
| Diluted Average Shares | 156,602,836 |
| Assets | $327.08M |
| Current Assets | $295.92M |
| Accounts Receivable | $97.42M |
| Inventory | $7.71M |
| Other Current Assets | $190.78M |
| Noncurrent Assets | $31.16M |
| Fixed Assets | $971.00K |
| Other Non-current Assets | $30.19M |
| Liabilities | $671.35M |
| Current Liabilities | $153.78M |
| Accounts Payable | $5.36M |
| Other Current Liabilities | $148.42M |
| Noncurrent Liabilities | $517.57M |
| Long-term Debt | $164.59M |
| Other Non-current Liabilities | $352.98M |
| Equity | -$344.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$344.27M |
| Liabilities And Equity | $327.08M |
| Net Cash Flow From Operating Activities | -$36.69M |
| Net Cash Flow From Operating Activities, Continuing | -$36.69M |
| Net Cash Flow From Investing Activities | -$219.00K |
| Net Cash Flow From Investing Activities, Continuing | -$219.00K |
| Net Cash Flow From Financing Activities | $69.82M |
| Net Cash Flow From Financing Activities, Continuing | $69.82M |
| Net Cash Flow | $32.91M |
| Net Cash Flow, Continuing | $32.91M |
| Comprehensive Income/Loss | -$99.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$99.07M |
| Other Comprehensive Income/Loss | $0.00 |